Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28147865 | 0.98 | ALDH1A1 (0.32) | ALDH1A1CYP1A2HPGDTSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL9663743 | 0.98 | ALDH1A1 (0.32) | ALDH1A1CYP1A2HPGDTSHRHSD17B10 | |
| Benzoquinone SCHEMBL28848136 | 0.91 | MEN1 (0.31) | ALDH1A1MEN1CYP2D6MAPTKMT2A | |
| Phenol SCHEMBL28853126 | 0.90 | CA12 (0.35) | ALDH1A1CYP1A2HPGDTSHRHSD17B10 | |
| Glycolic Acid SCHEMBL27842488 | 0.87 | KMT2A (0.33) | ALDH1A1CYP1A2HPGDHSD17B10MEN1 | |
| SCHEMBL28011581 | 0.87 | — | — | |
| SCHEMBL27721548 | 0.86 | — | — | |
| Quinoxaline SCHEMBL27702672 | 0.86 | ALDH1A1 (0.34) | ALDH1A1HSD17B10CYP3A4MEN1CYP2D6 | |
| Oxazole SCHEMBL29224669 | 0.82 | — | — | |
| SCHEMBL27558547 | 0.80 | MEN1 (0.32) | ALDH1A1CYP1A2HPGDCYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116761854-A | Near Infrared (NIR) transparent neutral black solid solution pigment | 太阳化学有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-116669866-A | Near Infrared (NIR) transparent neutral black perylene solid solutions | 太阳化学有限公司 | 2023-08-29 | — | — | CN | claimed |
| EP-3180189-B1 | LINED PIPES AND FITTINGS, ASSOCIATED FORMING METHOD, AND METHOD OF IMPROVING THE CHLORINE RESISTANCE OF HIGH DENSITY POLYETHYLENE PIPES | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2018-03-28 | — | — | EP | claimed |
| CN-102165013-B | Biodegradable polymer mixtures | BASF SE | 2013-04-24 | — | — | CN | claimed |
| CN-101511938-B | Crosslinkable aramid copolymers | TEIJIN ARAMID BV | 2012-10-10 | — | — | CN | claimed |
| CN-102165013-A | Biodegradable polymer mixtures | BASF SE | 2011-08-24 | — | — | CN | claimed |
| CN-101879152-A | The method of treatment HCV disease | NOVARTIS AG | 2010-11-10 | — | — | CN | claimed |
| CN-101855199-A | Tricyclic amide compound | RES FOUND ITSUU LAB | 2010-10-06 | — | — | CN | claimed |
| CN-101511938-A | Crosslinkable aramid copolymers | TEIJIN ARAMID BV (NL) | 2009-08-19 | — | — | CN | claimed |
| CN-101090716-A | Methods of treating HCV disorders | NOVARTIS AG (CH) | 2007-12-19 | — | — | CN | claimed |
| CN-1088727-C | Thermosetting resin composition, solidifying material, preformed material metal armoured laminated plate and circuit board | HITACHI KASEI IND CO LTD (JP) | 2002-08-07 | — | — | CN | claimed |
| CN-1053680-C | Thermosetting compounds, cured product thereof and method of preparing the thermosetting compound | HITACHI CHEMICAL CO LTD (JP) | 2000-06-21 | — | — | CN | claimed |
| EP-0765199-B1 | IRON POWDER COMPONENTS CONTAINING THERMOPLASTIC RESIN AND METHOD OF MAKING SAME | HOEGANAES AB (SE) | 2000-05-31 | — | — | EP | claimed |
| CN-1161986-A | Thermosetting resin composition, solidifying material, preformed material metal armoured laminated plate and circuit board | HITACHI KASEI IND CO LTD (JP) | 1997-10-15 | — | — | CN | claimed |
| CN-1111649-A | Thermosetting compounds, cured product thereof and method of preparing the thermosetting compound | HITACHI CHEMICAL CO LTD (JP) | 1995-11-15 | — | — | CN | claimed |
| EP-0228020-B1 | POLY(PHENYLENE ETHER)-BOUND UV ABSORBER | GENERAL ELECTRIC COMPANY (US) | 1992-07-01 | — | — | EP | claimed |
| US-12614736-B2 | Fuel cell graphene-based material for capturing catalyst particles | ROBERT BOSCH GMBH (DE) | 2026-04-28 | — | — | US | disclosed |
| CN-113451595-B | Fuel cell catalyst material with defective carbon-based coating | 罗伯特·博世有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-1111649-A | Thermosetting compounds, cured product thereof and method of preparing the thermosetting compound | HITACHI CHEMICAL CO LTD (JP) | 1995-11-15 | — | — | CN | disclosed |
| US-5086080-A | PROCESS FOR THE PREPARATION OF EXPANDABLE BEADS | MONTEDIPE S.R.L. (IT) | 1992-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12614736-B2 | Fuel cell graphene-based material for capturing catalyst particles | TIMM9, TIMM13, FECH | ALDH1A1 2970/4885CYP1A2 1154/4885HPGD 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.